Pyo Jung-Soo, Kim Joo Heon
Department of Pathology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Republic of Korea, 95 Dunsanseo-ro, Seo-gu, Daejeon, 35233, Republic of Korea.
Pathol Oncol Res. 2018 Jul;24(3):547-555. doi: 10.1007/s12253-017-0274-7. Epub 2017 Jul 6.
The aim of this study was to elucidate the clinicopathological characteristics of the micropapillary (MP) subtype and its correlation with survival in lung adenocarcinoma. We investigated the clinicopathological characteristics, including the incidence, sex, smoking history, tumor size, lymph node metastasis, lymphovascular invasion, distant metastasis, genetic alteration, and prognosis in lung adenocarcinoma with the MP pattern through a meta-analysis. From 48 eligible studies, 19,502 lung adenocarcinomas were included. The incidence rate of the MP pattern was 0.101 [95% confidence interval (CI) 0.075-0.136]. There was no significant difference between stage I and III tumors. Lung adenocarcinoma with the MP pattern showed higher rates of lymphatic invasion (0.526, 95% CI 0.403-0.645). MP pattern was found in 0.150 (95% CI 0.008-0.790) of lung adenocarcinoma with distant metastasis. In lung adenocarcinoma with the MP pattern, the estimated rates of ALK, EGFR, and KRAS mutations were 0.102 (95% CI 0.027-0.322), 0.620 (95% CI 0.444-0.769), and 0.118 (95% CI 0.027-0.393), respectively. The MP pattern of lung adenocarcinoma was significantly correlated with worse overall and disease-free survival rates (hazard ratio 1.704, 95% CI 1.216-2.387, and 2.082, 95% CI 1.541-2.813, respectively). Taken together, identification of the MP pattern in lung adenocarcinoma is useful for prediction of clinicopathological characteristics and prognosis of patients.
本研究旨在阐明微乳头(MP)亚型肺腺癌的临床病理特征及其与生存的相关性。我们通过荟萃分析研究了具有MP模式的肺腺癌的临床病理特征,包括发病率、性别、吸烟史、肿瘤大小、淋巴结转移、淋巴管侵犯、远处转移、基因改变和预后。从48项符合条件的研究中,纳入了19502例肺腺癌。MP模式的发病率为0.101[95%置信区间(CI)0.075 - 0.136]。I期和III期肿瘤之间无显著差异。具有MP模式的肺腺癌显示出更高的淋巴管侵犯率(0.526,95% CI 0.403 - 0.645)。在有远处转移的肺腺癌中,MP模式的发生率为0.150(95% CI 0.008 - 0.790)。在具有MP模式的肺腺癌中,ALK、EGFR和KRAS突变的估计发生率分别为0.102(95% CI 0.027 - 0.322)、0.620(95% CI 0.444 - 0.769)和0.118(95% CI 0.027 - 0.393)。肺腺癌的MP模式与较差的总生存率和无病生存率显著相关(风险比分别为1.704,95% CI 1.216 - 2.387和2.082,95% CI 1.541 - 2.813)。综上所述,识别肺腺癌中的MP模式有助于预测患者的临床病理特征和预后。